Prediction of poor survival by cyclooxyg
β
Wen-Cheng Chen; William H. McBride; Shih-Ming Chen; Kam-Fai Lee; Tzer-Zen Hwang;
π
Article
π
2005
π
John Wiley and Sons
π
English
β 731 KB
Background. This study was undertaken to determine the status of cyclooxygenase-2 (COX-2) in nasopharyngeal cancer (NPC) in Taiwanese patients and its relationship to survival after radiotherapy (RT). In addition, the effect of NS-398, a potent selective COX-2 inhibitor, was tested in vitro alone an